Foley & Lardner’s Dallas Office Announces Three New Partners: Christopher J. Babcock, Thomas Scannell and Dovi Adlerstein
February 2, 2021
D Magazine
Just recently, 19 Foley & Lardner employees were promoted, including the transition of two senior counsels and one counsel to partner roles at the Dallas office.
Christopher J Babcock previously served as a senior counsel, focusing on private equity, corporate governance, and securities matters. He also represented clients across a broad range of corporate governance and capital market matters, including tender offers, public exchange offers, and more.
Thomas Scannell also served as senior counsel in the firm’s restructuring and reorganization practice. His focus is the restructuring of companies in and out of bankruptcy, debtors’ and creditors’ rights, and debtor-in-possession financers.
Dovi Adlerstein served as counsel and a business lawyer. His specialties include structuring, negotiating, and implementing all phases of mergers and acquisitions, corporate recapitalizations, and private equity transactions.
Christopher J Babcock previously served as a senior counsel, focusing on private equity, corporate governance, and securities matters. He also represented clients across a broad range of corporate governance and capital market matters, including tender offers, public exchange offers, and more.
Thomas Scannell also served as senior counsel in the firm’s restructuring and reorganization practice. His focus is the restructuring of companies in and out of bankruptcy, debtors’ and creditors’ rights, and debtor-in-possession financers.
Dovi Adlerstein served as counsel and a business lawyer. His specialties include structuring, negotiating, and implementing all phases of mergers and acquisitions, corporate recapitalizations, and private equity transactions.
People
Related News
January 6, 2026
In the News
Kyle Faget Weighs in on Pharmaceutical Industry Legal Battles
Foley & Lardner LLP partner Kyle Faget shared insight with Law360 on major legal topics affecting the pharmaceutical industry.
January 2, 2026
In the News
Judith Waltz Shares Insights on Key Health Law Developments on AHLA Podcast
Foley & Lardner LLP partner Judith Waltz hosted the American Health Law Association's Speaking of Health Law podcast to discuss major health law developments from 2025 and offer insights on trends expected in 2026.
January 2, 2026
In the News
Rajiv Dharnidharka Examines Trade Secret Litigation Trends
Foley & Lardner LLP partner Rajiv Dharnidharka commented on anticipated developments in trade secret law this year in the Law360 article, “Trade Secret Trends To Watch In 2026.”